U.S. Advises Daily Truvada For Sexually Active At High AIDS Infection Risk
This article was originally published in PharmAsia News
Executive Summary
India makers of generic versions of Gilead's Truvada (tenofovir/emtricitabine) are in line for a huge jump in sales in the wake of U.S. health authorities' recommendation it be used by people sexually at high risk for AIDS infections.